Skip to Content


An Open-Label Study to Evaluate the Long-Term Safety and Effectiveness of Pitolisant in Adult Patients with Idiopathic Hypersomnia Who Completed Study HBS-101-CL-010

Aims: The purpose of the study is to evaluate the long-term safety and effectiveness of pitolisant in adult patients with idiopathic hypersomnia (IH) who have completed the double-blind randomized withdrawal phase of HBS-101-CL-010. Patients who complete study HBS-101-CL-010 will have up to 7 days from the end of treatment Visit/Visit 5 to enroll in study HBS-101-CL-011 and begin open-label pitolisant.
Principal Investigator: Thomas Freedom, MD
NorthShore Project Number: EH22-371
Contact: Call 847.570.1864 with questions regarding the study
Open to Enrollment: No